The largest database of trusted experimental protocols

Acquity uplc system

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Acquity UPLC system is a high-performance liquid chromatography (HPLC) instrument developed by Thermo Fisher Scientific. It is designed to provide efficient and accurate separation and analysis of a wide range of chemical compounds. The Acquity UPLC system utilizes advanced technology to achieve superior resolution, sensitivity, and speed compared to traditional HPLC systems.

Automatically generated - may contain errors

22 protocols using acquity uplc system

1

UPLC-Orbitrap Velos Pro Metabolomics

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Waters Acquity UPLC system coupled to a Thermo LTQ-Orbitrap Velos Pro mass spectrometer was used for metabolomic analysis. The mass spectrometer was equipped with a heated electrospray ionization (ESI) source and was operated in the FT mass spectrometry (MS) scan mode with mass resolution of 60,000 full-width at half-maximum at m/z 400. The m/z detection range was 80–1,200. A Waters BEH C18 UPLC column (2.1 mm × 50 mm, 1.7 μm) was used for chromatographic separation with the mobile phases being water–formic acid (0.01%; solvent A) and acetonitrile–formic acid (0.01%; solvent B). The binary solvent elution gradient was 5–40% B in 6 min and 40–100% B in 15 min. The mobile phase was kept at 100% B for 2 min before column equilibration with 5% B for 4 min between injections. The column temperature was 50 °C and the flow rate was 0.3 ml min−1. Two liquid chromatography (LC)–MS runs per sample were performed in the (+) and (−) ion detection modes, respectively. Lock mass calibration was applied to ensure mass accuracy throughout LC–MS runs.
+ Open protocol
+ Expand
2

Metabolomics Analysis by UPLC-Orbitrap-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serum samples and an equal volume of quality control (QC) samples (Supplementary Table 3) were deproteinated with cold methanol that contains internal standards. Ultra-Performance Liquid Chromatography-Orbitrap-Mass Spectrometry (UPLC-Orbitrap-MS) analysis was conducted on a Waters ACQUITY UPLC system coupled to a Thermo Scientific Orbitrap Fusion Lumos Tribrid mass spectrometer for mass spectrometry (MS) analysis. For detailed steps of UPLC-Orbitrap-MS, please see the Supplementary Materials and Methods.
+ Open protocol
+ Expand
3

Nano LC-MS/MS Identification of Protein Biomarkers

Check if the same lab product or an alternative is used in the 5 most similar protocols
After completing the statistical analysis, selected peptides or proteins biomarkers were further purified and separated by Nano Aquity UPLC C18 beads and serially eluted with 5% and 95% acetonitrile. These proteins and peptides biomarkers were identified directly by a nano-liquid chromatography- electrospray ionization-tandem mass spectrometry system (LC-ESI-MS/MS) consisting of an Acquity UPLC system and an LTQ Orbitrap XL mass spectrometer (Thermo Fisher) equipped with a Nano-ESI source. The settings of the Nano Ion Source are as follows: spray voltage, 1.8 kV; MS scan time, 60 min; and scanning range, m/z 400 to 2000. Obitrap was used for the first scan (MS), with a resolution of 100000, and LTQ was used for the CID and the second scan (MS/MS). The acquired data were searched against the UniProt protein sequence database of HUMAN (http://www.uniprot.org).
+ Open protocol
+ Expand
4

Untargeted Metabolomic Profiling of Jiupei Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Untargeted metabolomic analysis to identify the differential metabolites between the different Jiupei samples was done using GC–MS and LC–MS. GC–MS analysis was performed using a 7890A gas chromatograph (Agilent) coupled to a PEGASUS HT mass selective detector (LECO). LC–MS analysis was performed on an Acquity UPLC system (Thermo Fisher Scientific) coupled with a Q Exactive HFX (Thermo Fisher Scientific). The detailed sample preparation and MS analysis methods are described in Text S1 (Sun et al., 2020 (link)).
+ Open protocol
+ Expand
5

Metabolite Quantification in Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Methods for metabolite level determination were previously described [38 (link)]. Metabolite extracts were prepared from 50 μL of fasting plasma stored at −80 °C via protein precipitation with 250 μL of acetonitrile, evaporation under nitrogen, and reconstitution in 50 μL of water. Three reference human plasma samples were prepared in each analytical batch as a control within and between analyses. UPLC-MS was performed using a Waters Acquity UPLC system coupled to a Thermo Scientific Q Exactive mass spectrometer. A proportion of values were below the lower limits of quantification (LLOQ) for 5HT (21.4%; LLOQ: 0.00113 μM) and 5HIAA (3.6%; 0.0131 μM) and were imputed as LLOQ/√2 (5HT:0.000799 μM; 5HIAA:0.00926 μM), as previously described [38 (link)].
+ Open protocol
+ Expand
6

Metabolic Profiling of Baseline Serum Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Baseline serum specimens were subjected to global profiling (Metabolon, Durham, NC). The Metabolon platform uses gas chromatography and liquid chromatography mass spectrometry in positive and negative modes (15 (link),16 (link)). The liquid chromatography mass spectrometry portion of the platform incorporates a Waters ACQUITY UPLC system and a Finnigan LTQ mass spectrometer (Thermo Fisher Scientific), including an electrospray ionization source and linear ion trap mass analyzer. The gas chromatography column is 5% phenyl dimethyl silicone, and the temperature ramp is from 40°C to 300°C over 16 min. All samples were then analyzed on a Finnigan TRACE DSQ fast-scanning single-quadrupole mass spectrometer (Thermo Fisher Scientific) using electron impact ionization. After peak identification and quality control filtering, the metabolite-relative concentrations were obtained from median-scaled day-block normalized data for each compound. Samples in this study were run in batches balanced by case status.
+ Open protocol
+ Expand
7

Synthesis and Purification of Organic Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Unless otherwise noted, all reagents from commercial sources were used without further purification. Reactions were monitored by thin-layer chromatography (TLC) using TLC plates precoated with TLC silica gel 60 F254 (Merck KGaA). Spots on TLC were visualized either directly with an ultraviolet light or after staining with p-anisaldehyde stain. Flash column chromatography was conducted on 40–63 µm silica gel. Unless otherwise stated, NMR spectra were obtained on a Varian Mercury 300 (300 MHz) in CDCl3. The reported chemical shifts for the 1H NMR spectra were recorded in parts per million (ppm) on the δ scale from an internal tetramethylsilane standard (0.0 ppm) and reported consecutively as position, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, dd = doublet of doublets, m = multiplet, and br = broad), coupling constant (J/Hz), relative integral, and assignment. High-resolution mass spectra (HRMS) were obtained on a Waters Acquity UPLC system equipped with a ThermoFisher QExactive mass spectrometer with electrospray ionization (ESI) operated in positive ionization mode. The purity of the final products was determined by HPLC.
+ Open protocol
+ Expand
8

Optimized LC-MS Metabolite Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each sample extract designated for LC–MS analysis was split into two aliquots, dried, and reconstituted in acidic or basic LC-compatible solvents, each of which contained eight or more injection standards at fixed concentrations to ensure injection and chromatographic consistency. The analysis of LC/MS samples performed on the platform using a Waters ACQUITY UPLC system and a Thermo Fisher Scientific Orbitrap Elite high resolution/accurate mass spectrometer, which was composed of a heated electrospray ionization (HESI) source and an orbitrap mass analyzer operating at 30,000 mass resolution. Samples were analyzed using acidic positive ion optimized conditions (one aliquot) and basic negative ion optimized conditions (second aliquot) in two independent injections on separate dedicated columns. Extracts reconstituted in acidic conditions were gradient eluted using water and methanol containing 0.1% formic acid, while the basic extracts used water/methanol containing 6.5 mM ammonium bicarbonate. The MS analysis alternated between MS and data-dependent MS2 scans using dynamic exclusion.
+ Open protocol
+ Expand
9

Analytical Workflow for Compound Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analyses were performed on an Acquity UPLC system interfaced to an Orbitrap Q-Exactive Focus mass spectrometer (Thermo Scientific) using a heated electrospray ionization source (HESI-II) and an Acquity UPLC PDA detector. Thermo Scientific Xcalibur 2.1 software was employed for instrument control. The detailed conditions are presented in Supplementary Section S9.
+ Open protocol
+ Expand
10

Quantifying Brain Cortex Acylcarnitines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The whole brain cortex was also used to measure several different acylcarnitine metabolites using an UPLC-MS method as previously described43 (link). In short, 5 mg of pulverized tissue was homogenized in 50 µl of PBS before 25 µl of deuterated labeled internal standards was added. Proteins were removed by adding a solution of methanol/dichloromethane (v/v, 600 µl) to the sample mixture. The sample was centrifuged at 18,000×g for 15 min at 4 °C, and then the supernatant was transferred to a 1 dram vial, and dried under N2 stream. Samples were reconstituted and analyzed on a Waters Acquity UPLC system (Milford, MA) coupled with a Thermo Quantiva tandem mass spectrometer (West Palm Beach, FL) in positive (H)ESI mode. Concentrations of carnitine (162.1 > 85.0 m/z), acetylcarnitine (204.1 > 85.0 m/z), propionylcarnitine (218.1 > 85.0 m/z), butyrylcarnitine (232.1 > 85.0 m/z), isovalerylcarnitine (246.1 > 85.0 m/z), octanoylcarnitine (288.2 > 85.0 m/z), lauroylcarnitine (344.3 > 85.0 m/z), myristoylcarnitine 372.3 > 85.0 m/z), palmitoylcarnitine (400.4 > 85.0 m/z), oleoylcarnitine (426.4 > 85.0 m/z), and stearoylcarnitine (438.4 > 85.0 m/z) were measured against a 11-point calibration curve that underwent the same preparation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!